The ALS-FTD-Q
Authors:
- Joost RaaphorstJRJoost Raaphorst
- Emma BeeldmanEBEmma Beeldman
- Ben SchmandBSBen Schmand
- Joris BerkhoutJBJoris Berkhout
- Wim H.J.P. LinssenWLWim H.J.P. Linssen
- Leonard H. van Den BergLBLeonard H. van Den Berg
- Yolande A. PijnenburgYPYolande A. Pijnenburg
- Hepke F. GrupstraHGHepke F. Grupstra
- Janneke G. WeikampJWJanneke G. Weikamp
- H. Jurgen SchelhaasHSH. Jurgen Schelhaas
- Janne M. PapmaJPJanne M. Papma
- John C. van SwietenJSJohn C. van Swieten
- 25 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 79 (13) , 1377-1383
Abstract
The assessment of behavioral disturbances in amyotrophic lateral sclerosis (ALS) is important because of the overlap with the behavioral variant of frontotemporal dementia (ALS-bvFTD). Motor symptoms and dysarthria are not taken into account in currently used behavioral questionnaires. We examined the clinimetric properties of a new behavioral questionnaire for patients with ALS (Amyotrophic Lateral Sclerosis-Frontotemporal Dementia-Questionnaire [ALS-FTD-Q]). In addition to other clinimetric properties, we examined reliability, clinical validity, and construct validity of the ALS-FTD-Q, using data from patients with ALS (n = 103), ALS-bvFTD (n = 10), bvFTD (n = 25), muscle disease control subjects (n = 39), and control subjects (n = 31). Construct validity of the ALS-FTD-Q was assessed using the Frontal Systems Behavior scale (FrSBe), Frontal Behavioral Inventory (FBI), Hospital Anxiety and Depression Scale, ALS Functional Rating Scale-Revised, Frontal Assessment Battery, Mini-Mental State Examination, and a fluency index. In addition, the point prevalence of behavioral disturbances according to the ALS-FTD-Q was compared with those obtained with the FrSBe and FBI. The internal consistency of the ALS-FTD-Q was good (Cronbach α = 0.92). The ALS-FTD-Q showed construct validity because it correlated highly with other behavioral measures (r = 0.80 and 0.79), moderately with measures of frontal functions and global cognitive functioning (r = 0.37; r = 0.32), and poorly with anxiety/depression and motor impairment (r = 0.18 for both). The ALS-FTD-Q discriminated between patients with ALS-bvFTD, patients with ALS, and control subjects. The point prevalence of behavioral disturbances in patients with ALS measured with the ALS-FTD-Q was lower than that for the FrSBe and FBI. The ALS-FTD-Q is a feasible and clinimetrically validated instrument for the screening of behavioral disturbances in ALS.Keywords
This publication has 35 references indexed in Scilit:
- Predicting survival in frontotemporal dementia with motor neuron diseaseNeurology, 2011
- Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodologyJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of lifeEuropean Journal of Neurology, 2010
- How common are behavioural changes in amyotrophic lateral sclerosis?Amyotrophic Lateral Sclerosis, 2010
- Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRIAmyotrophic Lateral Sclerosis, 2010
- Frontal‐lobe mediated behavioral dysfunction in amyotrophic lateral sclerosisEuropean Journal of Neurology, 2009
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Detecting neurobehavioral changes in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2007
- The Neuropsychiatric InventoryNeurology, 1994
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983